Details of Disease

General Information of Disease (ID: DISVVCXG)

Disease Name Proliferative lupus nephritis
Disease Class 4A40: Lupus erythematosus
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISVVCXG: Proliferative lupus nephritis
ICD Code
ICD-11
ICD-11: 4A40

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Vemircopan DM3RZ9H Phase 2 Small molecule [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 ClinicalTrials.gov (NCT05097989) A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of ALXN2050 in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN). U.S.National Institutes of Health.